Case Studies – The Catapult Network

Browse Catapults

Case Studies from across the Catapults

Search

Themes

Cross-Catapult (2),
Cell and Gene Therapy (16),
Compound Semiconductor Applications (13),
Connected Places (14),
Digital (14),
Energy Systems (14),
High Value Manufacturing (17),
Medicines Discovery (15),
Offshore Renewable Energy (14),
Satellite Applications (14),

Catapults (Reset)

Cell and Gene Therapy

alt=

INmune Bio partners with Cell and Gene Therapy Catapult to scale up CORDStrom™ manufacturing for commercial readiness

Cell and Gene Therapy

INmune Bio partners with Cell and Gene Therapy Catapult to scale up CORDStrom™ manufacturing for commercial readiness

Cell and Gene Therapy

How can the UK drive cell and gene therapy skills?

The Cell and Gene Therapy Catapult is placing the UK at the centre of a global cell and gene therapy industry. It is committed to the advancement of cell and gene therapies and has a vision for a thriving industry delivering life-changing advanced therapies to the world.

Cell and Gene Therapy

Upskilling the UK to take full advantage of the potential of cell and gene therapies

Cell and Gene Therapy Catapult is a global leader in skills in a rapidly growing sector. Through a range of initiatives such as the world’s first apprenticeship programme for cell and gene therapies and a national training network it now supports a sector employing almost 7,000 people from across the UK, with the workforce predicted to grow to over 15,000 by 2026.

Cell and Gene Therapy

alt=

Delivering safer advanced therapies, faster and at lower cost through technology and process innovation

At its core, Cell and Gene Therapy Catapult is an innovation and technology company. Its work with industry in the development of novel processes and analytical techniques for cell and gene therapy manufacture has supported significant investment into startup businesses as well as attracting international manufacturers such as Rentschler to invest in manufacturing in the UK.

Cell and Gene Therapy

alt=

Establishing Stevenage as a global leader for cell and gene therapies

UK Government invested £72m in the Cell and Gene Therapy Catapult centre in Stevenage. This has led to the creation of one of the leading cell and gene therapy clusters globally and brought £1.5bn to the region through the 45 companies that are now investing there.

Cell and Gene Therapy

alt=

The Cell and Gene Therapy Catapult: bringing new jobs, investment and long-term business success to Stevenage

Stevenage, which lies about 30 miles north of London, was named the UK’s first ‘New Town’ in 1946. For many years its population relied on the engineering jobs and skills developed by British Aerospace. But times have changed and today Stevenage stands at the forefront of an entirely new generation of advanced healthcare technology and discovery.

Cell and Gene Therapy

The Cell and Gene Therapy Catapult: bringing new jobs, investment and long-term business success to Stevenage

Stevenage, which lies about 30 miles north of London, was named the UK’s first ‘New Town’ in 1946. For many years its population relied on the engineering jobs and skills developed by British Aerospace. But times have changed and today Stevenage stands at the forefront of an entirely new generation of advanced healthcare technology and discovery.

Cell and Gene Therapy

alt=

Growing new capabilities with German company Rentschler Biopharma SE

Cell and Gene Therapy Catapult partnered with German based Rentschler Biopharma to enable the establishment of new ATMP development and manufacturing capabilities in the UK, to benefit the UK and international demand and further strengthen the UK ecosystem and international supply chain.

Cell and Gene Therapy

Growing new capabilities with German company Rentschler Biopharma SE

Cell and Gene Therapy Catapult partnered with German based Rentschler Biopharma to enable the establishment of new ATMP development and manufacturing capabilities in the UK, to benefit the UK and international demand and further strengthen the UK ecosystem and international supply chain.

Cell and Gene Therapy

Powering up the cell and gene therapy industry in the UK

Cell and Gene Therapy Catapult is building the world’s most complete advanced therapies ecosystem, creating UK industry attractiveness with potential for inward investment and export.

Cell and Gene Therapy

Becoming a beacon of equality, diversity and inclusion within the Cell and Gene Therapy sector

Cell and Gene Therapy Catapult prides itself on having a diverse, inclusive and balanced workforce and aims to create an environment where people are fully supported and feel that they can be themselves at work, irrespective of skin colour, age, sexuality and disability.

Cell and Gene Therapy

alt=

Advancing acute myeloid leukaemia cell therapy

A collaboration between the Cell and Gene Therapy Catapult, University College London and Imperial College London advances a novel cell therapy for the treatment of acute myeloid leukaemia.

Cell and Gene Therapy

alt=

Developing treatments for chronic kidney disease

University spin-out Purespring Therapeutics sought expert input from the Cell and Gene Therapy Catapult to efficiently progress their pre-clinical development plans and secured one of the largest single investment to a UK biotech company from global healthcare giant Syncona.

Cell and Gene Therapy

alt=

Pioneering technology to increase effectiveness of gene therapeutics

A collaboration between the Cell and Gene Therapy Catapult and Synpromics set out to develop novel scalable manufacturing processes and technologies to produce viral vectors at scale.

Cell and Gene Therapy

Pioneering technology to increase effectiveness of gene therapeutics

A collaboration between the Cell and Gene Therapy Catapult and Synpromics set out to develop novel scalable manufacturing processes and technologies to produce viral vectors at scale.

Cell and Gene Therapy

alt=

Enabling the development of potentially life-saving therapies

The emergence of cell therapies will potentially change the landscape of healthcare. The Cell and Gene Therapy Catapult, identified the need for a cell thawing system that would reduce barriers to the commercialisation.

Cell and Gene Therapy

Enabling the development of potentially life-saving therapies

The emergence of cell therapies will potentially change the landscape of healthcare. The Cell and Gene Therapy Catapult, identified the need for a cell thawing system that would reduce barriers to the commercialisation.

Cell and Gene Therapy

Developing large scale manufacture and supply of cell and gene therapies

The Cell and Gene Therapy Catapult Manufacturing Centre facilitates collaborating companies to produce living medicines at scale, supporting clinical trials and commercial supply.

Page 1 of 1